Bayesian analysis of data from both trials showed that levofloxacin reduced the risk of developing TB by 60 percent
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.